Psoriasis Treatment Market Size

Psoriasis Treatment Market Overview

As per MRFR analysis, the Psoriasis Treatment Market Size was estimated at 9.04 (USD Billion) in 2022. The Psoriasis Treatment Market Industry is expected to grow from 9.75(USD Billion) in 2023 to 19.3 (USD Billion) by 2032. The Psoriasis Treatment Market CAGR (growth rate) is expected to be around 7.88% during the forecast period (2024 - 2032).

Key Psoriasis Treatment Market Trends Highlighted

The Psoriasis Treatment Market is primarily driven by a high number of population suffering from psoriasis and also the increasing awareness levels. The market is also characterized by increasing investment in biopharmaceutical companies focusing on the development of effective psoriasis therapies and biologics, which are helping to transform the treatment facets for patients. Moreover, the rising number of clinical trials aimed at new drug development also substantially works towards improving the treatment avenues. The growth of targeted therapies is also encouraging progress by enabling caregivers to give more comprehensive treatment on a case-by-case basis thus enhancing patient experience and outcomes.

This market presents many opportunities especially through the use of technology improvement tapping into the surge of telemedicine. Remote screen applications for psoriasis are a core part of the management of the condition helping the patients to access care virtually and follow the treatment prescribed more easily. Furthermore, there is great potential in original markets where there is a growth in healthcare systems for increasing the treatment provision. The use of wearables to monitor patient’s skin conditions can also enhance the patient’s involvement and ability to manage their condition, thus shifting treatment strategies toward a prevention model. Most recently, combination therapies aimed at complementing systemic approaches with topical ones are gaining traction.

Another key area that seems to be gaining focus is dealing with the comorbidities that go with psoriasis. Also, acceptance of biosimilars is on the increase as they are low-cost alternatives to conventional biologic therapies, which in turn enhances patient options for much-needed therapy. As the market develops in the future, partnerships between pharmaceutical companies and health care professionals will also likely determine the course management of psoriasis.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Psoriasis Treatment Market Drivers

Increasing Prevalence of Psoriasis

The Psoriasis Treatment Market Industry is significantly driven by the increasing prevalence of psoriasis across the globe. Psoriasis is a chronic autoimmune condition characterized by periods of flare-ups and remission, affecting millions of people worldwide. As awareness regarding this condition grows, more individuals are seeking medical help, thereby boosting the demand for effective treatments. The number of diagnosed cases continues to rise, influenced by various factors, including lifestyle changes, environmental stressors, and possibly genetic predispositions.

As a result, healthcare providers are increasingly focusing on developing and introducing new therapies, which in turn propels the market forward. With a remarkable CAGR projected for the upcoming years, the Psoriasis Treatment Market Industry is poised for growth as companies innovate to meet the needs of a growing patient population. The integration of advanced treatment modalities such as biologics and targeted therapies is transforming the landscape, offering hope for more effective and personalized treatment options.

Patient advocacy and education campaigns are also being initiated to raise awareness about psoriasis, further driving market demand. These initiatives create a conducive environment for market expansion as the healthcare community becomes more engaged in managing this prevalent condition.

Advancements in Treatment Technologies

Recent advancements in treatment technologies have profoundly influenced the Psoriasis Treatment Market Industry. Innovations such as biologic drugs, which target specific parts of the immune system, are changing the treatment landscape for psoriasis. These therapies have shown significant efficacy in reducing symptoms and improving the quality of life for patients suffering from moderate to severe psoriasis. Furthermore, the emergence of new formulations and delivery methods, including topical treatments, systemic therapies, and phototherapy, are providing various options tailored to individual patient needs.

This continuous evolution of treatment methodologies represents a major driver of growth in the market. Companies are heavily investing in research and development to bring more effective options to healthcare providers and patients alike.

Growing Awareness and Education

The growing awareness and education about psoriasis and its treatment options is a key driver of growth in the Psoriasis Treatment Market Industry. As public knowledge about this chronic condition increases, more individuals are motivated to seek treatments, leading to higher market demand. Healthcare providers are also placing a greater emphasis on educating patients about their condition, fostering a better understanding and management of psoriasis.

Programs aimed at reducing the stigma around skin conditions contribute to more patients seeking help and discussing treatment options with their physicians, which ultimately enhances the growth potential for the market.

Psoriasis Treatment Market Segment Insights

Psoriasis Treatment Market Treatment Type Insights

The Psoriasis Treatment Market revenue is notable, with the market poised for continued growth, reflecting an evolving landscape in healthcare solutions for psoriasis. Most prominently, the Treatment Type segment reveals a clear trajectory of market dynamics, with significant contributions from various methodologies. In 2023, Topical Treatments captured a market valuation of 3.7 USD Billion, consolidating its foothold as a major approach among treatment modalities. This method remains favored due to its accessibility and direct application, catering to patients seeking immediate, localized relief from symptoms.

Systemic Treatments are also a central part of this market segmentation, accounting for 4.25 USD Billion in 2023. This treatment type is essential as it addresses psoriasis on a broader scale, effectively engaging with immune responses and offering a more holistic approach to chronic sufferers. The increased prevalence of moderate to severe psoriasis underscores its significance, as Systemic Treatments cater to patients with more impactful manifestations of the disease. Meanwhile, Phototherapy, valued at 1.8 USD Billion in 2023, represents an emerging yet crucial segment within the landscape of psoriasis management.

Though it holds the smallest share, its significance lies in its ability to harness the therapeutic effects of ultraviolet light, proving beneficial for individuals who may not respond adequately to topical or systemic solutions. The phased growth across these varied Treatment Types manifests in an opportunity to cater to a diverse patient base with tailored interventions, supporting expanding market growth and driving innovation in treatment methodologies. The interplay between efficacy, accessibility, and patient comfort is pivotal in shaping the Psoriasis Treatment Market Statistics, reflecting a comprehensive understanding of how each type interacts with the unique needs of patients.

In summary, as the market evolves, the importance of Treatment Type diversification becomes increasingly prominent, paving the way for holistic management strategies that address the complexities of psoriasis on multiple fronts. The Psoriasis Treatment Market Industry is set for continued exploration and innovation, ensuring that each treatment type can adapt and thrive in tandem with the changing healthcare environment.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Psoriasis Treatment Market Therapy Class Insights

The Therapy Class segment of the Psoriasis Treatment Market showcases a transformative landscape, with the overall market expected to reach a valuation of 9.75 billion USD by 2023 and see considerable growth thereafter. The market growth is significantly driven by the increasing prevalence of psoriasis and the rising demand for effective treatment options. The market segmentation highlights diverse approaches, including Biologics, which are at the forefront due to their targeted action and superior efficacy in moderate to severe cases, indicating their dominant position in the market.

Traditional Systemic Therapies remain a staple for many patients, providing reliable results, while Topical Corticosteroids are widely utilized due to their accessibility and quick action. Retinoids also play a vital role, often employed for their ability to modify skin cell production, while Calcineurin Inhibitors serve as essential alternatives for sensitive skin areas, marking their relevance in comprehensive treatment plans. The Psoriasis Treatment Market statistics reveal a dynamic interplay among these therapy classes, driven by continual advancements in medical research and innovative formulations.

As the market evolves, there lie substantial opportunities for growth in emerging therapies, emphasizing the importance of adaptability in treatment strategies.

Psoriasis Treatment Market Route of Administration Insights

The Route of Administration segment is a crucial part of the Psoriasis Treatment Market, which was valued at 9.75 billion USD in 2023 and is on track for significant expansion. This segment encompasses various methods, including Topical, Oral, Injectable, and Intravenous treatments. Topical treatments hold substantial importance due to their direct application to the skin, providing localized relief and reducing systemic side effects. Oral medications are also significant, as they offer convenience for patients who prefer pills over injections.

Injectable therapies are gaining traction due to their ability to deliver biologics effectively, thus enhancing treatment efficacy. Intravenous administration, while less common, is vital for treating severe cases of psoriasis, ensuring rapid and effective delivery of therapeutic agents. As the Psoriasis Treatment Market revenue continues to grow, the dynamics within each route of administration will evolve, reflecting changing patient preferences and advancements in treatment modalities. The overall market growth is driven by the increasing prevalence of psoriasis and the demand for effective treatments, while challenges such as access and cost play a role in shaping this landscape.

The Psoriasis Treatment Market data and statistics indicate a robust future for this segment, with each route offering unique advantages and playing a prominent role in patient management.

Psoriasis Treatment Market Patient Age Group Insights

The Psoriasis Treatment Market, valued at 9.75 USD Billion in 2023, reflects significant insights, especially when considering Patient Age Group dynamics. The market segmentation reveals diverse treatment needs among various age brackets, with a notable focus on Pediatric, Adult, and Geriatric patients. Pediatric patients require specially formulated treatments due to their developing immune systems, drawing increased attention from pharmaceutical developers. The Adult demographic constitutes a substantial portion of the market, as psoriasis frequently manifests during early adulthood, highlighting the urgency for effective management solutions. Furthermore, the Geriatric population is gaining importance due to the rising incidence of chronic conditions such as psoriasis accompanied by age-related factors.
This age group segmentation illustrates how tailored treatment approaches can address specific challenges, ensuring effective management. The Psoriasis Treatment Market data also indicates that increasing awareness and research into the condition are vital growth drivers, enabling these segments to receive more focused therapies. As the industry evolves, understanding these dynamics will be crucial for stakeholders aiming to capitalize on opportunities within the Psoriasis Treatment Market industry. Continued innovation and adaptation in treatment strategies for all age groups will enhance market growth and improve patient outcomes.

Psoriasis Treatment Market Regional Insights

The Psoriasis Treatment Market revenue demonstrates substantial growth across different regions, with North America commanding a dominant position, valued at 4.6 USD Billion in 2023 and expected to reach 9.3 USD Billion by 2032. This majority holding is driven by advanced healthcare infrastructure and high prevalence rates of psoriasis. Europe follows as a significant player, valued at 2.8 USD Billion in 2023, growing to 5.6 USD Billion by 2032, propelled by robust pharmaceutical sectors and innovative treatment options. The Asia-Pacific region holds a notable valuation of 1.8 USD Billion in 2023, contributing to expanding market growth due to increasing awareness and rising healthcare spending, projected to increase to 3.8 USD Billion by 2032.

South America shows a modest valuation of 0.9 USD Billion in 2023, with potential growth to 1.7 USD Billion, reflecting emerging opportunities in developing healthcare systems. Lastly, the Middle East and Africa, valued at 0.65 USD Billion in 2023, expanding to 1.5 USD Billion, showcase the evolving market landscape driven by healthcare improvements and access to treatment options. This Psoriasis Treatment Market segmentation highlights varying regional dynamics, with North America and Europe leading due to their established healthcare systems, while APAC, South America, and MEA present growth opportunities amid increasing awareness and healthcare accessibility.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Psoriasis Treatment Market Key Players and Competitive Insights:

The Psoriasis Treatment Market is characterized by a dynamic and competitive landscape, with various pharmaceutical companies striving to develop innovative therapies for this chronic skin condition. Psoriasis affects millions of individuals worldwide, influencing their quality of life and creating a significant demand for effective treatment options. This market is marked by the presence of a range of therapies, including biologics, systemic medications, and topical treatments, all aimed at alleviating the symptoms of psoriasis while addressing the underlying inflammatory processes. Key players in the market are continually engaged in research and development activities, seeking to enhance their product offerings and meet the evolving needs of patients by integrating advanced technologies and personalized treatment strategies.

BristolMyers Squibb has established itself as a significant player in the Psoriasis Treatment Market through its commitment to innovative therapies and robust research pipeline. The company has made notable progress in the development of biological treatments that target specific pathways implicated in the pathogenesis of psoriasis. BristolMyers Squibb’s strong emphasis on clinical trials and its ability to bring effective solutions to market has garnered it a solid reputation among healthcare professionals and patients alike. The company's proactive approach to addressing unmet medical needs and investing in cutting-edge science enhances its competitive positioning, allowing it to leverage its successes in improving patient outcomes, thereby increasing its presence in the psoriasis treatment segment.

Merck is another key competitor in the Psoriasis Treatment Market, offering a diversified portfolio of treatment options aimed at managing psoriasis effectively. The company is known for its strategic focus on research and development, particularly in the area of novel therapies that harness the body's immune system to combat psoriasis. With a strong commitment to clinical excellence and a well-established distribution network, Merck is capable of effectively reaching healthcare providers and patients. The company’s ability to innovate and adapt its strategies in response to market demands strengthens its competitive edge within the psoriasis treatment landscape, allowing it to maintain a prominent position while actively contributing to advancements in the management of this chronic condition.

Key Companies in the Psoriasis Treatment Market Include

• BristolMyers Squibb


• Merck


• Lilly


• Eli Lilly and Company


• Regeneron Pharmaceuticals


• Sanofi


• Celgene


• AbbVie


• Gilead Sciences


• Amgen


• Johnson and Johnson


• Pfizer


• UCB


• AstraZeneca


• Novartis

Psoriasis Treatment Market Industry Developments

Recent developments in the Psoriasis Treatment Market have seen increased focus on new therapies and innovations from major pharmaceutical companies such as Bristol-Myers Squibb, Merck, Eli Lilly and Company, and AbbVie. This surge is attributed to rising prevalence rates of psoriasis worldwide and the demand for more effective treatment options. Merck and Pfizer have made strides in enhancing their portfolios by launching advanced biologics, which aim to provide better efficacy and improved patient outcomes. There have also been notable movements regarding mergers and acquisitions; for example, the consolidation efforts among firms like Amgen and Johnson & Johnson are indicative of a growing trend to enhance competitive edge and expand market reach. Companies like Sanofi and Regeneron Pharmaceuticals are focusing on collaborations to develop novel therapies, which is contributing to overall growth in market valuation. The financial landscape reflects significant investments in research and development, showcasing the rapid evolution of treatment options, including targeted therapies and oral medications. This competitive environment is fostering innovation, leading to enhanced accessibility of treatments and better management of psoriasis symptoms for patients globally.

Psoriasis Treatment Market Segmentation Insights

Psoriasis Treatment Market Treatment Type Outlook

• Topical Treatments


• Systemic Treatments


• Phototherapy

Psoriasis Treatment Market Therapy Class Outlook

• Biologics


• Traditional Systemic Therapies


• Topical Corticosteroids


• Retinoids


• Calcineurin Inhibitors

Psoriasis Treatment Market Route of Administration Outlook

• Topical


• Oral


• Injectable


• Intravenous

Psoriasis Treatment Market Patient Age Group Outlook

• Pediatric


• Adult


• Geriatric

Psoriasis Treatment Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa